Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LncRNA MST1P2/miR‐133b axis affects the chemoresistance of bladder cancer to cisplatin‐based therapy via Sirt1/p53 signaling
Jia Chen, Yuanwei Li, Zhiqiu Li, et al.
Journal of Biochemical and Molecular Toxicology (2020) Vol. 34, Iss. 4
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms
Fei Li, Zaosong Zheng, Wei Chen, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100938-100938
Closed Access | Times Cited: 97
Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies
Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115242-115242
Open Access | Times Cited: 28
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 42
Sirtuin1-p53: A potential axis for cancer therapy
Jiayi Yin, Xin-tong Lu, Meng-Ling Hou, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115543-115543
Closed Access | Times Cited: 18
Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review
Masoud Najafi, Shima Tavakol, Ali Zarrabi, et al.
Archives of Physiology and Biochemistry (2020) Vol. 128, Iss. 6, pp. 1438-1452
Closed Access | Times Cited: 48
LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin
Mohammad Taheri, Hamed Shoorei, Farhad Tondro Anamag, et al.
Experimental and Molecular Pathology (2021) Vol. 123, pp. 104602-104602
Closed Access | Times Cited: 39
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Milad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, et al.
Current Cancer Drug Targets (2021) Vol. 21, Iss. 8, pp. 640-665
Closed Access | Times Cited: 34
Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology
Sarath Babu Nukala, Jordan Jousma, Yoonje Cho, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
Ying Du, Gang Geng, Zhao Chun-quan, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 24
lncRNA-mediated ceRNA network in bladder cancer
Kun Li, Tongyue Yao, Ziqiang Wang
Non-coding RNA Research (2022) Vol. 8, Iss. 2, pp. 135-145
Open Access | Times Cited: 23
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System
Dominik A. Barth, Jaroslav Juráček, Ondřej Slabý, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2148-2148
Open Access | Times Cited: 37
Biological functions and clinical significance of long noncoding RNAs in bladder cancer
Yan Zhang, Xianwu Chen, Juntao Lin, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 32
Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 185, pp. 106475-106475
Closed Access | Times Cited: 21
Role of Long Non-coding RNAs on Bladder Cancer
Hui-Jin Li, Xue Gong, Zhengkun Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26
The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment
Sanjna Das, Joshua P. Hayden, Travis Sullivan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 964-964
Open Access | Times Cited: 9
Non coding RNAs as the critical factors in chemo resistance of bladder tumor cells
Amir Sadra Zangouei, Hamid Reza Rahimi, Majid Mojarrad, et al.
Diagnostic Pathology (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 25
MicroRNA‑133b alleviates doxorubicin‑induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2
Zhen Li, Zekang Ye, Jiazheng Ma, et al.
International Journal of Molecular Medicine (2021) Vol. 48, Iss. 1
Open Access | Times Cited: 22
Interaction between SIRT1 and non-coding RNAs in different disorders
Soudeh Ghafouri‐Fard, Hamed Shoorei, Bashdar Mahmud Hussen, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 8
MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing
Sheng Zhang, Qin Wang, Wenfeng Li, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 12
Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
Mehrdad Hashem, Elaheh Mohandesi Khosroshahi, Melika Aliahmady, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 560-582
Open Access | Times Cited: 2
Long noncoding RNA MST1P2 promotes cervical cancer progression by sponging with microRNA miR-133b
Rongrong Xu, Xiaoyue Zhang, Yan Xu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 1851-1860
Open Access | Times Cited: 15
ADNP prompts the cisplatin-resistance of bladder cancer via TGF-β-mediated epithelial-mesenchymal transition (EMT) pathway
Yu Xie, Shuai Zhu, Jinglei Zang, et al.
Journal of Cancer (2021) Vol. 12, Iss. 17, pp. 5114-5124
Open Access | Times Cited: 15
The LINC01410/miR‐122‐5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells
Weiguo Ma, Xin Zhao, Ning Xue, et al.
IUBMB Life (2021) Vol. 73, Iss. 4, pp. 705-717
Open Access | Times Cited: 12
RETRACTED ARTICLE: Reduced LINC00467 elevates microRNA-125a-3p to suppress cisplatin resistance in non-small cell lung cancer through inhibiting sirtuin 6 and inactivating the ERK1/2 signaling pathway
Feng Xue, Chuan Yang, Keli Yun, et al.
Cell Biology and Toxicology (2021) Vol. 39, Iss. 1, pp. 365-365
Open Access | Times Cited: 12
Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance
Forough Alemi, Yadollah Poornajaf, Foroogh Hosseini, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top